The Effects of Bruton Tyrosine Kinase Inhibition on Chemotaxis and Superoxide Generation in Human Neutrophils

被引：0
|
作者：
Arnon Broides
Nurit Hadad
Jacov Levy
Rachel Levy
机构：
[1] Soroka University Medical Center,Pediatric Immunology Clinic
[2] Soroka University Medical Center,Infectious Disease Laboratory, Department of Clinical Biochemistry
[3] Soroka University Medical Center,Faculty of Health Sciences
[4] Ben-Gurion University of the Negev,undefined
来源：
Journal of Clinical Immunology | 2014年 / 34卷
关键词：
Bruton tyrosine kinase; neutrophil; superoxide; chemotaxis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：555 / 560
页数：5
相关论文
共 50 条
  • [41] A phase II study of Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis
    Suresh, Ragha, V
    Dunnam, Collin
    Vaidya, Dhananjay
    Wood, Robert A.
    Bochner, Bruce S.
    MacGlashan Jr, Donald W.
    Dispenza, Melanie C.
    JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (16):
  • [42] Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease
    Stefan F. H. Neys
    Jasper Rip
    Rudi W. Hendriks
    Odilia B. J. Corneth
    Drugs, 2021, 81 : 1605 - 1626
  • [43] Bruton's Tyrosine Kinase Inhibition in the Treatment of Preclinical Models and Multiple Sclerosis
    Steinmaurer, Anja
    Wimmer, Isabella
    Berger, Thomas
    Rommer, Paulus S.
    Sellner, Johann
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (06) : 437 - 444
  • [44] Bruton's Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease
    Neys, Stefan F. H.
    Rip, Jasper
    Hendriks, Rudi W.
    Corneth, Odilia B. J.
    DRUGS, 2021, 81 (14) : 1605 - 1626
  • [45] Inhibition of the Bruton Tyrosine Kinase Pathway in B-Cell Lymphoproliferative Disorders
    Castillo, Jorge J.
    Treon, Steven P.
    Davids, Matthew S.
    CANCER JOURNAL, 2016, 22 (01): : 34 - 39
  • [46] Bruton-Tyrosinkinase-Inhibition in Dermatologie und AllergologieBruton tyrosine kinase inhibition in dermatology and allergology
    B. Wedi
    Der Hautarzt, 2018, 69 (6): : 519 - 522
  • [47] Inhibition of superoxide production and chemotaxis by methotrexate in neutrophils primed by TNF-alpha or LPS
    Okuda, A
    Kubota, M
    Watanabe, K
    Sawada, M
    Koishi, S
    Kataoka, A
    Usami, I
    Lin, YW
    Furusho, K
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1997, 59 (03) : 142 - 147
  • [48] Inhibition of Bruton's tyrosine kinase as a novel therapeutic approach in multiple sclerosis
    Torke, Sebastian
    Weber, Martin S.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (10) : 1143 - 1150
  • [49] BRUTON'S TYROSINE KINASE INHIBITION TO SUPPRESS MAST CELL ACTIVATION IN ATHEROSCLEROSIS
    Hemme, E.
    Delfos, L.
    Depuydt, M. A. C.
    Kleijn, M. N. A. Bernabe
    Schaftenaar, F. H.
    Foks, A. C.
    Kuiper, J.
    Bot, I.
    ATHEROSCLEROSIS, 2022, 355 : E100 - E100
  • [50] Bruton Tyrosine Kinase Inhibition: an Effective Strategy to Manage Waldenström Macroglobulinemia
    Tawfiq, Reema K.
    Abeykoon, Jithma P.
    Kapoor, Prashant
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2024, 19 (03) : 120 - 137
12345